Evidence map›Paper›PMID 34900962›Full record

ArticleFrontiers in bioengineering and biotechnology2021

A New Nanomaterial Based on Extracellular Vesicles Containing Chrysin-Induced Cell Apoptosis Through Let-7a in Tongue Squamous Cell Carcinoma.

Zhijing Yang, Da Liu, Hengzong Zhou, Boqiang Tao, Lu Chang, Huimin Liu, Haoming Luo, Dongxu Wang, Weiwei Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Innovative nanoparticle strategies for treating oral cancers.Medical oncology (Northwood, London, England) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhijing YangDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Da LiuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Hengzong ZhouLaboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.
Boqiang TaoDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Lu ChangDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Huimin LiuDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Haoming LuoDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Dongxu WangLaboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.
Weiwei LiuDepartment of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Jilin University · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the therapeutic strategy showed significant improvement, the therapeutic effect was poor on metastases in tongue squamous cell carcinoma (TSCC) which is the most malignant tumor found in the head and neck. Chrysin, similar to the flavonoids, plays an antitumor role by regulating the expression of ncRNAs in many kinds of cancers. Compared to flavonoids, gold nanoparticles (AuNPs) provide a novel insight into inhibiting cancer cell growth via photothermal therapy (PPT) which is irradiated by near-infrared radiation (NIR). However, most flavonoids and AuNPs lack specificity of tumor

Indexed as

cell apoptosisextracellular vesiclesgold nanoparticleslet-7atongue squamous cell carcinoma

Identifiers

PMID34900962
PMCPMC8661124
OpenAlexW3215749480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.